ArticleThe British journal of cardiology2024
Artificial intelligence in heart valve disease: diagnosis, innovation and treatment. A state-of-the-art review.
Article in The British journal of cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Mechanical-medical convergence in heart failure: Artificial intelligence, finite-element modeling, and 3D printing for diagnosis and prognosis.Bioengineering & translational medicine · 2026Review
- Amplatzer-Based Transcatheter Paravalvular Leak Closure: A Narrative Review of Device Design, Procedural Strategy, Safety, and Outcomes.Life (Basel, Switzerland) · 2026Review
- Artificial intelligence across the cardiovascular diagnostic pathway: a case-based narrative review.Cardiovascular diagnosis and therapy · 2026Review
- The cyber-physical paradigm for lifetime aortic valve management: a synthesis of robotics, artificial intelligence, and augmented reality.Journal of robotic surgery · 2026Review
- Multimodal diagnostic imaging for early mitral valve disease: integration of current and emerging modalities-a narrative review.Cardiovascular diagnosis and therapy · 2025Review
- Applications of Artificial Intelligence in Transcatheter Aortic Valve Replacement: A Review of the Literature.Life (Basel, Switzerland) · 2025Review
- Ethnic variation in aortic root anatomy and prosthesis sizing in TAVI: a UK matched study.European heart journal. Imaging methods and practice · 2025Article
- Future of Valvular Heart Disease and Structural Heart Interventions: Why So Much Excitement?Journal of personalized medicine · 2025Article
- Contemporary Clinical Treatment Options and Outcomes of Aortic Valve Disease: Integrating Modern Insights into a Cohesive Therapeutic Paradigm.Journal of cardiovascular development and disease · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent years, artificial intelligence (AI) has been used to improve the precision of valvular heart disease diagnosis and treatment. It has the ability to identify and risk stratify patients with valvular heart disease and holds promise in improving the innovation of new treatments through shorter, safer and more effective clinical trials. AI can help to guide the treatment of patients with valvular heart disease, by aiding in optimal device selection for transcatheter valvular interventions and, potentially, predicting the risk of specific complications. This review article explores the various potential applications of AI in the diagnosis and treatment of valvular heart disease in more detail.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.